These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 28412856
1. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease. Çerçi P, Altıner S, İnal A, Köse K, Keskin G, Ölmez Ü. Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856 [Abstract] [Full Text] [Related]
2. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations. Fawzy RM, Said EA, Mohamed SM, Fouad NA, Akl EM. Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139 [Abstract] [Full Text] [Related]
3. Serum IL-33 levels and skin mRNA expression in Behçet's disease. Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F. Clin Exp Rheumatol; 2013 Jun; 31(3 Suppl 77):6-14. PubMed ID: 23464866 [Abstract] [Full Text] [Related]
4. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease? Keskin D, Keskin G, Inal A, Ozışık L. Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748 [Abstract] [Full Text] [Related]
5. The importance of serum interleukin-20 levels in patients with Behçet's disease. Enecik ME, Mavi B, Yücel Ç, Keskin G, Yıldız M. Adv Clin Exp Med; 2018 Oct; 27(10):1391-1395. PubMed ID: 30048054 [Abstract] [Full Text] [Related]
6. Increased serum interleukin-32 levels in patients with Behçet's disease. Ha YJ, Park JS, Kang MI, Lee SK, Park YB, Lee SW. Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461 [Abstract] [Full Text] [Related]
7. Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease. Freire Ade L, Bertolo MB, de Pinho AJ, Samara AM, Fernandes SR. Clin Rheumatol; 2004 Jun; 23(3):203-5. PubMed ID: 15168145 [Abstract] [Full Text] [Related]
8. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease. Novak T, Hamedi M, Bergmeier LA, Fortune F, Hagi-Pavli E. Front Immunol; 2021 Jun; 12():724900. PubMed ID: 35003055 [Abstract] [Full Text] [Related]
9. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease. Evereklioglu C, Er H, Türköz Y, Cekmen M. Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429 [Abstract] [Full Text] [Related]
10. The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behçet's disease. Wang LM, Kitteringham N, Mineshita S, Wang JZ, Nomura Y, Koike Y, Miyashita E. Arch Dermatol Res; 1997 Jul; 289(8):444-7. PubMed ID: 9266021 [Abstract] [Full Text] [Related]
11. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation? Pay S, Abbasov T, Erdem H, Musabak U, Simsek I, Pekel A, Akdogan A, Sengul A, Dinc A. Clin Exp Rheumatol; 2007 Jul; 25(4 Suppl 45):S70-5. PubMed ID: 17949555 [Abstract] [Full Text] [Related]
12. IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features. Zarrabi M, Gholijani N, Shenavandeh S, Aflaki E, Amirghofran Z. Eur Cytokine Netw; 2019 Sep 01; 30(3):82-87. PubMed ID: 31957702 [Abstract] [Full Text] [Related]
13. Interleukin-27 gene variant rs153109 is associated with enhanced cytokine serum levels and susceptibility to Behçet's disease in the Iranian population. Gholijani N, Daryabor G, Kalantar K, Yazdani MR, Shenavandeh S, Zahed M, Jafarpour Z, Malekmakan MR, Amirghofran Z. Eur Cytokine Netw; 2020 Dec 01; 31(4):140-146. PubMed ID: 33648922 [Abstract] [Full Text] [Related]
14. Lack of association between serum IL-9 levels and Behçet's disease. Nouri-Vaskeh M, Malek Mahdavi A, Khabbazi A, Jadideslam G. Immunol Lett; 2019 Jul 01; 211():23-27. PubMed ID: 31095970 [Abstract] [Full Text] [Related]
15. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis? Pay S, Erdem H, Pekel A, Simsek I, Musabak U, Sengul A, Dinc A. Rheumatol Int; 2006 May 01; 26(7):608-13. PubMed ID: 16205926 [Abstract] [Full Text] [Related]
16. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients. Sonmez C, Yucel AA, Yesil TH, Kucuk H, Sezgin B, Mercan R, Yucel AE, Demirel GY. Clin Rheumatol; 2018 Oct 01; 37(10):2797-2804. PubMed ID: 29557072 [Abstract] [Full Text] [Related]
17. Serum IL-33 level and IL-33 gene polymorphisms in Behçet's disease. Koca SS, Kara M, Deniz F, Ozgen M, Demir CF, Ilhan N, Isik A. Rheumatol Int; 2015 Mar 01; 35(3):471-7. PubMed ID: 25119832 [Abstract] [Full Text] [Related]
18. Levels of IL-15 in serum and cerebrospinal fluid of patients with Behçet's disease. Hamzaoui K, Hamzaoui A, Ghorbel I, Khanfir M, Houman H. Scand J Immunol; 2006 Dec 01; 64(6):655-60. PubMed ID: 17083622 [Abstract] [Full Text] [Related]
19. Levels of soluble E-selectin in patients with active Behcet's disease. Sari RA, Kiziltunç A, Taysi S, Akdemir S, Gündoğdu M. Clin Rheumatol; 2005 Feb 01; 24(1):55-9. PubMed ID: 15338451 [Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome. Cekmen M, Evereklioglu C, Er H, Inalöz HS, Doganay S, Türköz Y, Ozerol IH. Int J Dermatol; 2003 Nov 01; 42(11):870-5. PubMed ID: 14636202 [Abstract] [Full Text] [Related] Page: [Next] [New Search]